activeview acquisition software (BioSemi)
90
Structured Review
BioSemi
activeview acquisition software
Activeview Acquisition Software, supplied by BioSemi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activeview+data+acquisition+software/activeview+acquisition+software/pmc06819273-201-9-12
Average 90 stars, based on 1 article reviews
Activeview Acquisition Software, supplied by BioSemi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activeview+data+acquisition+software/activeview+acquisition+software/pmc06819273-201-9-12
Average 90 stars, based on 1 article reviews
activeview acquisition software - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Impoverished auditory cues limit engagement of brain networks controlling spatial selective attention Article Snippet: .. 32-channel scalp EEG data was recorded (Activetwo system with Article Title: Weak neural signatures of spatial selective auditory attention in hearing-impaired listeners Article Snippet: .. EEG data were recorded in 32 electrodes and sampled at 4096 Hz using the BioSemi ActiveTwo system along with its Article Title: Weak neural signatures of spatial selective auditory attention in hearing-impaired listeners Article Snippet: .. EEG data were recorded in 32 electrodes and sampled at 4096 Hz using the BioSemi ActiveTwo system along with its Article Title: Contrasting losses and gains increases the predictability of behavior by frontal EEG asymmetry Article Snippet: .. Continuous EEG was recorded from 0.5–80 Hz and digitized at 256 Hz, using Article Title: Impoverished auditory cues limit engagement of brain networks controlling spatial selective attention Article Snippet: .. EEG Acquisition and Preprocessing 32-channel scalp EEG data was recorded (Activetwo system with other:Article Title: Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline. Article Snippet: Early diagnosis and timely treatment of Parkinson’s disease are essential factors to provide these patients with a longer period of a better quality of life.. Olfactory loss is among the first non-motor symptoms of the disease; however, in light of the many causes of smell loss, it is a very unspecific biomarker and should only be used as part of a diagnostic test battery.. In this study, we investigated the olfactory response in 71 subjects, consisting of Parkinson’s disease patients, hyposmic and anosmic patients of other causes, and normosmic individuals searching for sensitive, distinct biomarkers for which we used scalp event-related 64-channel electroencephalography and psychophysical tests. |